Follow The Filings

MYO Myomo

Myomo earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MYO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MYO insider trades
  • $442K bought by 4 insiders
  • $182K sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Harry Kovelman Chief Medical Officer
    Sale
    $20K 15,844 shares at $1.27 15% of stake
    Traded Sep 11 Filed Oct 15
    ↗
  2. Milton Mayo Morris Director
    Sale
    $21K 15,000 shares at $1.41 6.7% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  3. Harry Kovelman Chief Medical Officer
    Sale
    $30K 17,500 shares at $1.73 14% of stake
    Traded Aug 20 Filed Aug 24
    ↗
  4. Thomas F Kirk Director
    Buy
    $51K 40,002 shares at $1.27 +6.1% to stake
    Traded Jun 5 Filed Jun 9
    ↗
  5. Micah Mitchell Chief Commercial Officer
    Sale
    $78K 90,231 shares at $0.8600 45% of stake
    Traded May 14 Filed Jun 8
    ↗
  6. Thomas F Kirk Director
    Buy
    $25K 25,000 shares at $0.9900 +4% to stake
    Traded May 28 Filed Jun 1
    ↗
  7. Harry Kovelman Chief Medical Officer
    Sale
    $32K 32,000 shares at $1.01 23% of stake
    Traded May 27–28 Filed May 28
    ↗
  8. Joseph M. Manko Jr. Director
    Buy
    $174K 201,197 shares at $0.8600 +9.5% to stake
    Traded May 14–15 Filed May 18
    ↗
  9. Thomas F Kirk Director
    Buy
    $68K 75,006 shares at $0.9100 +14% to stake
    Traded May 15–18 Filed May 18
    ↗
  10. Micah Mitchell Chief Commercial Officer
    Sale
    $78K 90,231 shares at $0.8600 45% of stake
    Traded May 14, 2025 Filed May 15
    ↗
  11. Heather C Getz Director
    Buy
    $14K 20,000 shares at $0.7000 +18% to stake
    Traded Mar 16 Filed Mar 17
    ↗
  12. Thomas F Kirk Director
    Buy
    $51K 72,000 shares at $0.7100 +15% to stake
    Traded Mar 13 Filed Mar 16
    ↗
  13. Heather C Getz Director
    Buy
    $51K 70,000 shares at $0.7300 +168% to stake
    Traded Mar 12 Filed Mar 12
    ↗
  14. Thomas F Kirk Director
    Buy
    $5,355 7,437 shares at $0.7200 +1.6% to stake
    Traded Nov 20–21 Filed Nov 24, 2025
    ↗
  15. Thomas Aloysius Crowley Jr. Director
    Buy
    $3,233 4,385 shares at $0.7400
    Traded Nov 18–19 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants and 12 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K/A 5.02,5.03,5.07,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.